Literature DB >> 9715461

[Ocular changes in primary hematologic diseases].

G E Lang1, C W Spraul, G K Lang.   

Abstract

Ocular manifestations can be the presenting symptom of hematological diseases. Ocular changes can be found in up to 90% of the patients depending on the underlying disease. Most patients with ocular manifestations however are asymptomatic. Hematological disorders can manifest in all structures and adnexa of the eye. The most common manifestations are conjunctival pallor and hemorrhages, intraretinal hemorrhages and cotton wool spots. Retinal infiltrates, manifestations in the lids, anterior segment, optic nerve, orbit and adnexa are rare. Different ocular manifestations in anemia, leukemia, malignant Non-Hodgkin lymphoma, Hodgkin's disease, chronic myeloproliferative diseases, plasmocytoma, myelodysplastic syndromes, coagulopathies, and reticulo-histiocytic diseases are described. Not only the underlying disease but also chemotherapy, bone marrow transplantation can lead to ocular complications.

Entities:  

Mesh:

Year:  1998        PMID: 9715461     DOI: 10.1055/s-2008-1034925

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  [Retinal manifestation in hematological diseases].

Authors:  M Rehak; N Feltgen; P Meier; P Wiedemann
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

2.  [Ocular findings in hematological diseases].

Authors:  G E Lang; S J Lang
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

3.  Ocular disorders in adult leukemia patients in Nigeria.

Authors:  Afekhide E Omoti; Caroline E Omoti; Rita O Momoh
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

4.  A case of leukemic retinopathy mimicking common ischemic retinopathies.

Authors:  Agnes Awuah; Kofi Asiedu; Madison Adanusa; Michael Ntodie; Ebo Acquah; Samuel Kyei
Journal:  Clin Case Rep       Date:  2015-12-09

5.  Ophthalmic manifestations of acute and chronic leukemias presenting to a tertiary care center in India.

Authors:  Jacob Koshy; M Joseph John; Satish Thomas; Gurvinder Kaur; Nitin Batra; Wilson J Xavier
Journal:  Indian J Ophthalmol       Date:  2015-08       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.